Institutional review boards (IRBs) and risk considerations for children.
Maloney
Dennis M
DM
The Deem Corporation, P.O. Box 44069, Omaha, NE 68144, USA.
D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000503:physiopathology; D002648:Child; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use; D026724:Ethical Review; D028744:Ethics Committees, Research; D033161:Government Regulation; D006805:Human Experimentation / Q000331:legislation & jurisprudence*; D006801:Humans; D009315:National Institute of Mental Health (U.S.); D033281:Nontherapeutic Human Experimentation / Q000331:legislation & jurisprudence; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
D003913:Dextroamphetamine